Document is current

Any future updates will be listed below

The efficacy of pivmecillinam: 3 days or 5 days t.i.d against community acquired uncomplicated lower urinary tract infections – a randomized, double-blinded, placebo-controlled clinical trial study protocol

Crossref DOI link: https://doi.org/10.1186/s12879-016-2022-0

Published Online: 2016-12-01

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark